October, 2020    SMM-219

Bayer’s Drop of the Future

With the rising importance of the ‘patient payer,’ the Bayer/One Drop business model brings together capabilities that neither firm possesses in full. Not only did this confirm the business model I predicted in my 2011 book “The Future of Pharma,” it also fitted in with how I saw it developing. This article explains the importance of such ‘holobionts’ in our industry.